The social demand is large, the growth is fast, the profit is large, and the pharmaceutical industry is called “sunrise industryâ€. The author is informed that Shanxi Province has obvious resource advantages in the development of medicine. Recently, the Shanxi Provincial Economic and Information Committee announced the "2018 Action Plan for the Pharmaceutical Industry of Shanxi Province". The plan pointed out that the development of Shanxi's pharmaceutical industry will be guided by major project construction, focusing on the construction of industrial clusters and gradually moving toward the middle and high-end. Pharmaceutical production (picture is taken by China Pharmaceutical Network) Pursuit of high quality development From the increase of high-quality project reserves, to the construction of industrial park clusters, to the improvement of the brand management system, it is not difficult to see that the detailed plan formulated by Shanxi Province for the development of the pharmaceutical industry has been closely focused on the main line of seeking high-quality development. Quality is the foundation of industrial development, especially for the pharmaceutical industry. The pharmaceutical industry in line with the green development concept is becoming a new engine for the economic transformation and development of Shanxi Province. It is understood that in recent years, the pharmaceutical industry policies have been intensively introduced. After the continuous supply-side reforms have triggered a series of changes and transformations in the industry, the pharmaceutical industry will welcome the industry trend of rapid market expansion and increasing industry concentration. Come to a high quality growth period. The increasingly strict regulatory system forces the pharmaceutical industry to seek long-term development based on quality improvement. In order to promote the high quality development of the pharmaceutical industry, Shanxi Province is taking action. Focus on industrial cluster construction Shanxi Province will increase the reserve of high-quality projects in the pharmaceutical industry, and actively promote the construction of 64 major projects including the establishment of a new Chinese medicine industrialization project by Guangyuyuan, the technical transformation project of Deyuantang, and the research and development and industrialization of anti-tumor drugs for Zhendong Pharmaceutical. . It is understood that Shanxi is focusing on the construction of industrial clusters, supporting the construction of key characteristic parks such as Datong Medical Park, Huairen Pharmaceutical and Chemical Industry Park, Taigu Food and Pharmaceutical Industrial Park, Changzhi Kangzhuang Industrial Park and Yuncheng Salt Lake Industrial Park; guiding new construction and relocation projects. The district entered the park and gathered in the three major industrial bases to continue to promote the construction of the three major bases of Jinbei chemical raw materials and preparations, Jinzhong proprietary Chinese medicines and Jinnan new special medicines. Shanxi Province will also encourage and guide small and medium-sized enterprises to carry out various forms of cooperation with leading enterprises, strengthen synergies in the fields of raw material supply, manufacturing, marketing and logistics, improve the level of professional cooperation, and cultivate and develop a group of good growth. Small and medium-sized enterprises promote the coordinated development of upstream and downstream enterprises and large and medium-sized enterprises in the industrial chain. Although the development of Shanxi's pharmaceutical industry has made positive progress, the province's pharmaceutical R&D innovation capability is still at a low level, and there is still a large gap between R&D investment and domestic and international levels. A strong technical talent support team has not yet been formed. Strong R&D and innovation capability is an indispensable condition for enterprise competition. Shanxi Province will “strengthen the construction of innovation system†as a key task, continue to integrate innovation resources of enterprises and research institutes, enhance the technological innovation capability of enterprises through cooperation, and cultivate talents for enterprise construction. Promote the marketization of R&D services. In recent years, the State issued a series of documents such as the Outline of Chinese Medicine Development Strategy (2016-2030) and the Chinese Medicine Law to provide support for the sustainable development of Chinese medicine. Shanxi Province will use the geographical advantage to release the development potential of Chinese medicine. It is understood that Shanxi Province is located in North China and has thousands of Chinese herbal medicines. Some of the local medicinal materials are of high quality and have obvious advantages in China. According to the advantages of resources and geographical environment, four Chinese herbal medicine production bases and four enterprises have been initially established. The self-built Chinese herbal medicine base has the self-sufficiency ability of high-quality raw materials and medicinal materials; it has well-known exclusive Chinese patent medicine products such as Ding Guier umbilical paste and compound Kushen injection, and its market share ranks among the top in the country. With the above opportunities and advantages, we will expand the construction of Chinese herbal medicines, focus on supporting the protection of exclusive varieties, strengthen secondary research and development, and cultivate large varieties of modern Chinese medicine, which will fully tap the potential of industrial development and enhance the added value of the industry. According to the strategic plan for the development of traditional Chinese medicine in Shanxi Province, by 2020, Shanxi should make the Chinese medicine industry one of the important pillar industries of the province's national economy. The Chinese medicine industry accounts for more than 30% of the total output value of the pharmaceutical industry. The level of intelligence of the Chinese medicine industry has reached a new level, and a number of well-known enterprises with modern Chinese medicine with international influence have further enhanced their contribution to the economy and society, laying a solid foundation for the comprehensive establishment of a strong province of Chinese medicine and the realization of “healthy Shanxiâ€. . Our spike ports are widely applied in transfusion soft bag packing issues. Our products have perfect sealing capacity and can fit in with soft pipe well. We have advanced product design and process craft.The patent design helps prevent falling rubber chip gasket,this ensures the product very low needle chip drop and good puncture retention,it can also reduce hospital complaints.Our ports are easy to open, can completely eliminate the impact of aluminum chips and give excellent safety performance.We now have ten thousand production workshop, local production under 100 class conditions, to ensure the cleanliness of the products. A special structure is adopted to ensure that the completely closed cover body can be opened quickly, and the safety and cleanliness of clinical use are guaranteed, and the patent certificate has been obtained. Spike Port,Disposable Infusion Spike Port,Medical Infusion Spike Port,Infusion Spike Port Suzhou CRH New Material Technology Co.,Ltd. , https://www.crh-health.com
Improve R&D and innovation
Shanxi supports the innovation and development of enterprises, screens and identifies the key annual projects of technological innovation and the common development guideline of key technologies, and continuously enhances the core competitiveness of enterprises and the level of industry development.
Give play to regional advantages and release the potential of Chinese medicine development